Search

Schrodinger Inc

Slēgts

SektorsVeselības aprūpe

17.48 -5.31

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

18.25

Max

18.82

Galvenie mērījumi

By Trading Economics

Ienākumi

66M

6M

Pārdošana

302K

59M

EPS

0.08

Peļņas marža

10.146

Darbinieki

850

EBITDA

65M

7.3M

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt (spēcīgs)

Prognoze 12 mēnešiem

+8.7% upside

Dividendes

By Acuity

Nākamie ieņēmumi

2026. g. 4. nov.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

217M

1.4B

Iepriekšējā atvēršanas cena

22.79

Iepriekšējā slēgšanas cena

17.48

Ziņu noskaņojums

By Acuity

64%

36%

290 / 340 Rangs Healthcare

Schrodinger Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 12. aug. 19:26 UTC

Macro Event
Correlated Moves

Shares higher during the session, influenced by the ETF's increase.

2026. g. 11. aug. 19:16 UTC

Shares of Schrodinger Inc. are trading higher, maintaining a position above the 20-day moving average amid no specific company news.

2026. g. 10. aug. 19:36 UTC

Schrodinger Inc's shares are higher today, continuing a six-day advance amid supportive market conditions and heightened geopolitical tensions affecting investor sentiment.

2026. g. 7. aug. 19:16 UTC

Correlated Moves

Schrodinger Inc shares are higher today, supported by a broader market trend and gains in the Russell 2000 Index, despite some macroeconomic uncertainties.

2026. g. 6. aug. 23:01 UTC

Schrodinger Inc shares declined in after-market trading, reversing gains from the previous four sessions. The stock remains above its 20-day moving average.

2026. g. 5. aug. 23:01 UTC

News

Schrodinger Inc reported second-quarter adjusted EPS of $0.08, surpassing estimates. Revenue reached $58.889 million, leading to higher after-market trading.

2026. g. 3. aug. 19:51 UTC

Correlated Moves

Schrodinger Inc shares are higher, reflecting broader market gains amid a drop in oil prices and positive sentiment in the technology sector.

2026. g. 31. jūl. 19:46 UTC

Correlated Moves

Schrodinger Inc shares are lower amid declining first-quarter results and broader market pressure, despite an earlier rebound from session lows.

2026. g. 30. jūl. 18:46 UTC

Correlated Moves

Schrodinger Inc. advanced during Thursday's session, supported by broader market gains despite earlier pulling back from a session high.

2026. g. 29. jūl. 20:51 UTC

Correlated Moves

Schrodinger Inc shares are lower in after-market trading, influenced by a broader market downturn and rising crude oil prices amid geopolitical tensions.

2026. g. 28. jūl. 23:01 UTC

Schrodinger Inc. shares declined in after-market trading, remaining below their 20-day moving average amid broader market strength and pressure on technology stocks.

2026. g. 27. jūl. 22:51 UTC

Schrodinger Inc. shares are higher in after-market trading, despite remaining below their 20-day moving average amid broader market dynamics and falling crude oil prices.

2026. g. 24. jūl. 15:11 UTC

Schrodinger Inc shares are declining today, continuing a downward trend since Thursday's close. A pullback in crude oil prices may be affecting investor sentiment.

2026. g. 20. jūl. 15:12 UTC

Correlated Moves

Schrodinger Inc. shares are lower amid a decline in the ARK Genomic Revolution ETF and broader market pressures, despite a slight rebound earlier in the session.

Salīdzinājums

Cenas izmaiņa

Schrodinger Inc Prognoze

Cenas mērķis

By TipRanks

8.7% augšup

Prognoze 12 mēnešiem

Vidējais 20.25 USD  8.7%

Augstākais 24 USD

Zemākais 17 USD

Pamatojoties uz 6 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Schrodinger Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt (spēcīgs)

6 ratings

5

Pirkt

1

Turēt

0

Pārdot

Noskaņojums

By Acuity

290 / 340 Rangs Veselības aprūpe

Ziņu noskaņojums

Liecība "Lāču" tendencei

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Zem vidējā

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Schrodinger Inc

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. It has a research collaboration and license agreement with Novartis AG to advance multiple development candidates. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.
help-icon Live chat